| Akcje insidera | 347 910 shares |
Wynik sentymentu insiderów
Ocena sentymentu insiderów pokazuje firmy, które są kupowane przez insiderów korporacyjnych.
Jest to wynik zaawansowanego, wieloczynnikowego modelu ilościowego, który identyfikuje spółki o najwyższym poziomie akumulacji informacji poufnych. Model rankingowy wykorzystuje kombinację liczby netto insiderów kupujących w ciągu ostatnich 90 dni, całkowitej liczby akcji kupionych jako procent akcji w obrocie oraz całkowitej liczby akcji posiadanych przez insiderów. Liczba ta waha się od 0 do 100, przy czym wyższe liczby wskazują na wyższy poziom akumulacji w porównaniu z innymi spółkami, a 50 to średnia.
Częstotliwość aktualizacji: codziennie
Ocena sentymentu kadry kierowniczej
Ocena sentymentu kadry kierowniczej pokazuje, że firmy są kupowane przez urzędników korporacyjnych.
Z definicji dyrektorzy korporacyjni to insiderzy korporacyjni, ale w przeciwieństwie do niektórych innych insiderów (10% akcjonariuszy i członków zarządu), dyrektorzy pracują dla firmy na co dzień i podczas handlu korzystają z własnych pieniędzy. (10% Akcjonariusze i członkowie zarządu często zarządzają funduszami zarządzających pieniędzmi innych osób). W związku z tym transakcje wykorzystujące informacje poufne dokonywane przez osoby z kadry kierowniczej mają znacznie większe znaczenie i powinny być odpowiednio traktowane.
Podobnie jak ocena sentymentu insiderów, ocena sentymentu kadry kierowniczej jest wynikiem zaawansowanego, wieloczynnikowego modelu ilościowego, który identyfikuje firmy o najwyższym poziomie akumulacji urzędników.
Częstotliwość aktualizacji: codziennie
Kluczowe wskaźniki insider
Ta karta pokazuje pozycję firmy według różnych wskaźników insider. Ranking według miary percentyla pokazuje, jak ta firma wypada na tle innych firm na rynkach amerykańskich. Wyższe rankingi wskazują na lepszą sytuację.
Na przykład ogólnie przyjmuje się, że kupowanie przez insiderów jest pozytywnym wskaźnikiem, zatem spółki z większą liczbą takich transakcji plasowałyby się wyżej niż spółki z mniejszą liczbą takich transakcji (lub nawet sprzedaży przez insiderów.
Liczba netto zakupów dokonanych przez insiderów (ranking)
N/A
Liczba netto zakupów dokonanych przez insiderów to łączna liczba insiderów kupujących pomniejszona o całkowitą liczbę insiderów sprzedających w ciągu ostatnich 90 dni. Tutaj pokazana jest miara percentyla (zakres od 0 do 100%).
Procent akcji kupowanych przez insiderów (ranking)
N/A
Procent akcji zakupionych przez insiderów to całkowita liczba akcji zakupionych przez insiderów pomniejszona o całkowitą liczbę akcji sprzedanych przez insiderów w ciągu ostatnich 90 dni, podzielona przez całkowitą liczbę akcji zakupionych przez insiderów i pomnożona przez 100.
Wykres handlu insider
Poniższy wykres przedstawia Biocept Inc transakcji zrealizowanych przez insiderów. Insiderzy to członkowie kadry kierowniczej, dyrektorzy lub znaczący inwestorzy w spółce. Ogólnie rzecz biorąc, dokonywanie transakcji w ich firmach przez osoby posiadające dostęp do informacji poufnych w oparciu o istotne, niepubliczne informacje jest generalnie nielegalne. Nie oznacza to, że dokonywanie jakichkolwiek transakcji we własnych firmach jest nielegalne. Muszą jednak zgłaszać wszystkie transakcje do SEC za pośrednictwem formularza 4.
Lista insiderów i wskaźniki rentowności
Ta tabela przedstawia listę znanych insiderów i jest generowana automatycznie na podstawie zgłoszeń ujawnianych SEC. Oprócz nazwisk, najnowszego tytułu oraz oznaczenia dyrektora, członka kierownictwa lub 10% właściciela, podajemy najnowsze ujawnione pakiety akcji. Dodatkowo, jeśli to możliwe, udostępniamy historyczne wyniki handlowe danego insidera. Historyczne wyniki handlowe to średnia ważona wyników rzeczywistych transakcji zakupu na otwartym rynku dokonanych przez insiderów. Więcej informacji na temat sposobu obliczania tej wartości obejrzyj webinar na YouTube.
See our leaderboard of most profitable insider traders.
| Insider | Średni zysk (%) | Posiadane Akcje |
Podział korygujący |
|---|
Report errors via our new Insider Auditing Tool
Śledź historię zakupów insiderów — analiza zysków krótkoterminowych
W tej sekcji analizujemy rentowność każdego nieplanowanego zakupu od poufnych informacji na otwartym rynku dokonanego w BIOC / Biocept Inc. Analiza ta pomaga zrozumieć, czy insider konsekwentnie generuje nietypowe zyski i czy warto ją śledzić. Analiza ta obejmuje okres jednego roku po każdej transakcji wyniki są teoretyczne .
Poniższa tabela przedstawia najnowsze zakupy na otwartym rynku, które nie były częścią planu handlu automatycznego.
Cena skorygowana to cena skorygowana o podział. Akcje skorygowane to akcje skorygowane o podział.
Śledź historię sprzedaży insider — analiza strat krótkoterminowych
W tej sekcji analizujemy możliwość uniknięcia krótkoterminowych strat w wyniku każdej nieplanowanej sprzedaży insidera na otwartym rynku dokonanej w BIOC / Biocept Inc. Konsekwentny wzorzec unikania strat może sugerować, że przyszłe transakcje sprzedaży mogą przewidywać spadki cen. Analiza ta obejmuje okres jednego roku po każdej transakcji wyniki są teoretyczne .
Poniższa tabela przedstawia najnowsze sprzedaże na otwartym rynku, które nie były częścią planu handlu automatycznego.
Cena skorygowana to cena skorygowana o podział. Akcje skorygowane to akcje skorygowane o podział.
Historia transakcji
Kliknij ikonę linku, aby zobaczyć pełną historię transakcji. Transakcje zgłoszone w ramach automatycznego planu handlowego 10b5-1 będą oznaczone znakiem X w kolumnie oznaczonej 10b-5.
| Plik Data |
Data transakcji |
Formularz | Wtajemniczony | Serce | Nazwa papieru wartościowego | Kod | Bezpośredni | Cena wykonania |
Cena jednostki |
Zmieniono jednostki |
Zmieniona wartość (1 tys.) |
Pozostałe opcje |
Pozostałe akcje |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-04-04 | 2022-03-31 | 4 | Taylor Darrell | BIOC | Stock Option (right to buy) | D | 2,32 | 15 450 | 15 450 | |||||
| 2022-04-04 | 2022-03-31 | 4 | Marchand Philippe | BIOC | Stock Option (right to buy) | D | 2,32 | 150 000 | 150 000 | |||||
| 2022-03-16 | 2022-02-28 | 4 | Taylor Darrell | BIOC | Stock Option (right to buy) | D | 2,39 | 134 550 | 134 550 | |||||
| 2022-03-02 | 2022-02-28 | 4 | Riccitelli Samuel D | BIOC | Stock Option (right to buy) | D | 2,39 | 250 000 | 250 000 | |||||
| 2022-03-02 | 2022-02-28 | 4 | Morales Antonino | BIOC | Stock Option (right to buy) | D | 2,39 | 150 000 | 150 000 | |||||
| 2021-12-10 | 2021-12-09 | 4 | HALE DAVID F | BIOC | Common Stock | D | 4,0664 | -71 | -0 | 796 | ||||
| 2021-12-10 | 2021-12-09 | 4 | HALE DAVID F By trust | BIOC | Common Stock | I | 4,0717 | -11 | -0 | 101 | ||||
| 2021-12-10 | 2021-12-09 | 4 | HALE DAVID F By LLC | BIOC | Common Stock | I | 4,0602 | -363 | -1 | 3 114 | ||||
| 2021-09-02 | 2021-09-02 | 4 | Nall Michael W. | BIOC | Performance-Based Employee Stock Option (right to buy) | D | 3,76 | 80 000 | 80 000 | |||||
| 2021-09-02 | 2021-09-02 | 4 | Nall Michael W. | BIOC | Employee Stock Option (right to buy) | D | 3,76 | 100 000 | 100 000 | |||||
| 2021-09-02 | 2021-08-31 | 4 | DUGAN MICHAEL C | BIOC | Employee Stock Option (right to buy) | D | 3,62 | 150 000 | 150 000 | |||||
| 2021-09-02 | 2021-08-31 | 4 | TERRY MICHAEL J | BIOC | Employee Stock Option (right to buy) | D | 3,62 | 35 000 | 35 000 | |||||
| 2021-09-02 | 2021-08-31 | 4 | Kennedy Timothy | BIOC | Employee Stock Option (right to buy) | D | 3,62 | 100 000 | 100 000 | |||||
| 2021-07-20 | 2021-07-16 | 4 | Wilson Margaret Faye | BIOC | Employee Stock Option (right to buy) | D | 3,77 | 10 000 | 10 000 | |||||
| 2021-07-20 | 2021-07-16 | 4 | Gerhardt Bruce | BIOC | Employee Stock Option (right to buy) | D | 3,77 | 10 000 | 10 000 | |||||
| 2021-07-20 | 2021-07-16 | 4 | HALE DAVID F | BIOC | Employee Stock Option (right to buy) | D | 3,77 | 10 000 | 10 000 | |||||
| 2021-07-20 | 2021-07-16 | 4 | Chandler Marsha Alpert | BIOC | Employee Stock Option (right to buy) | D | 3,77 | 10 000 | 10 000 | |||||
| 2021-07-20 | 2021-07-16 | 4 | Riccitelli Samuel D | BIOC | Employee Stock Option (right to buy) | D | 3,77 | 10 000 | 10 000 | |||||
| 2021-07-20 | 2021-07-16 | 4 | ROYSTON IVOR | BIOC | Employee Stock Option (right to buy) | D | 3,77 | 10 000 | 10 000 | |||||
| 2021-07-20 | 2021-07-16 | 4 | Rubinstein Linda M | BIOC | Employee Stock Option (right to buy) | D | 3,77 | 10 000 | 10 000 | |||||
| 2021-07-20 | 2021-07-16 | 4 | Morales Antonino | BIOC | Employee Stock Option (right to buy) | D | 3,77 | 10 000 | 10 000 | |||||
| 2021-07-20 | 3 | Rubinstein Linda M | BIOC | No securities are beneficially owned | D | 0 | ||||||||
| 2021-07-20 | 3 | Morales Antonino | BIOC | No securities are beneficially owned | D | 0 | ||||||||
| 2020-10-22 | 2020-10-20 | 4 | Riccitelli Samuel D | BIOC | Employee Stock Option (right to buy) | D | 4,63 | 10 000 | 10 000 | |||||
| 2020-10-05 | 2020-10-01 | 4 | Kennedy Timothy | BIOC | Employee Stock Option (right to buy) | D | 4,50 | 138 000 | 138 000 | |||||
| 2020-10-05 | 2020-10-01 | 4 | TERRY MICHAEL J | BIOC | Employee Stock Option (right to buy) | D | 4,50 | 48 300 | 48 300 | |||||
| 2020-10-05 | 2020-10-01 | 4 | DUGAN MICHAEL C | BIOC | Employee Stock Option (right to buy) | D | 4,50 | 69 000 | 69 000 | |||||
| 2020-10-05 | 2020-10-01 | 4 | Nall Michael W. | BIOC | Employee Stock Option (right to buy) | D | 4,50 | 241 500 | 241 500 | |||||
| 2020-09-01 | 2020-08-31 | 4 | DUGAN MICHAEL C | BIOC | Employee Stock Option (right to buy) | D | 0,66 | 54 900 | 54 900 | |||||
| 2020-08-27 | 3 | DUGAN MICHAEL C | BIOC | Common Stock | D | 5 700 | ||||||||
| 2020-06-12 | 2020-06-12 | 4 | HALE DAVID F | BIOC | Common Stock | D | 0,5550 | -556 | -0 | 867 | ||||
| 2020-06-12 | 2020-06-12 | 4 | HALE DAVID F By trust | BIOC | Common Stock | I | 0,5545 | -445 | -0 | 112 | ||||
| 2020-06-12 | 2020-06-12 | 4 | HALE DAVID F By LLC | BIOC | Common Stock | I | 0,5578 | -159 | -0 | 3 477 | ||||
| 2020-06-09 | 2020-06-05 | 4 | Wilson Margaret Faye | BIOC | Employee Stock Option (right to buy) | D | 0,48 | 500 | 500 | |||||
| 2020-06-09 | 2020-06-05 | 4 | Chandler Marsha Alpert | BIOC | Employee Stock Option (right to buy) | D | 0,48 | 500 | 500 | |||||
| 2020-06-09 | 2020-06-05 | 4 | Gerhardt Bruce | BIOC | Employee Stock Option (right to buy) | D | 0,48 | 500 | 500 | |||||
| 2020-06-09 | 2020-06-05 | 4 | HUEBNER BRUCE A | BIOC | Employee Stock Option (right to buy) | D | 0,48 | 500 | 500 | |||||
| 2020-06-09 | 2020-06-05 | 4 | ROYSTON IVOR | BIOC | Employee Stock Option (right to buy) | D | 0,48 | 500 | 500 | |||||
| 2020-06-09 | 2020-06-05 | 4 | HALE DAVID F | BIOC | Employee Stock Option (right to buy) | D | 0,48 | 500 | 500 | |||||
| 2019-06-19 | 2019-06-17 | 4 | Gerhardt Bruce | BIOC | Employee Stock Option (right to buy) | D | 1,02 | 500 | 500 | |||||
| 2019-06-19 | 2019-04-30 | 4 | Gerhardt Bruce | BIOC | Employee Stock Option (right to buy) | D | 0,91 | 30 000 | 30 000 | |||||
| 2019-06-19 | 2019-06-17 | 4 | Wilson Margaret Faye | BIOC | Employee Stock Option (right to buy) | D | 1,02 | 500 | 500 | |||||
| 2019-06-19 | 2019-04-30 | 4 | Wilson Margaret Faye | BIOC | Employee Stock Option (right to buy) | D | 0,91 | 30 000 | 30 000 | |||||
| 2019-06-19 | 2019-06-17 | 4 | ROYSTON IVOR | BIOC | Employee Stock Option (right to buy) | D | 1,02 | 500 | 500 | |||||
| 2019-06-19 | 2019-04-30 | 4 | ROYSTON IVOR | BIOC | Employee Stock Option (right to buy) | D | 0,91 | 30 000 | 30 000 | |||||
| 2019-06-19 | 2019-06-17 | 4 | HALE DAVID F | BIOC | Employee Stock Option (right to buy) | D | 1,02 | 500 | 500 | |||||
| 2019-06-19 | 2019-04-30 | 4 | HALE DAVID F | BIOC | Employee Stock Option (right to buy) | D | 0,91 | 30 000 | 30 000 | |||||
| 2019-06-19 | 2019-04-30 | 4 | Nall Michael W. | BIOC | Employee Stock Option (right to buy) | D | 0,91 | 675 000 | 675 000 | |||||
| 2019-06-19 | 2019-04-30 | 4 | TERRY MICHAEL J | BIOC | Employee Stock Option (right to buy) | D | 0,91 | 90 000 | 90 000 | |||||
| 2019-06-19 | 2019-04-30 | 4 | Hendrick Edwin | BIOC | Employee Stock Option (right to buy) | D | 0,91 | 160 000 | 160 000 | |||||
| 2019-06-19 | 2019-04-30 | 4 | ARNOLD LYLE J | BIOC | Employee Stock Option (right to buy) | D | 0,91 | 175 000 | 175 000 | |||||
| 2019-06-19 | 2019-06-17 | 4 | Chandler Marsha Alpert | BIOC | Employee Stock Option (right to buy) | D | 1,02 | 500 | 500 | |||||
| 2019-06-19 | 2019-04-30 | 4 | Chandler Marsha Alpert | BIOC | Employee Stock Option (right to buy) | D | 0,91 | 30 000 | 30 000 | |||||
| 2019-06-19 | 2019-06-17 | 4 | HUEBNER BRUCE A | BIOC | Employee Stock Option (right to buy) | D | 1,02 | 500 | 500 | |||||
| 2019-06-19 | 2019-04-30 | 4 | HUEBNER BRUCE A | BIOC | Employee Stock Option (right to buy) | D | 0,91 | 30 000 | 30 000 | |||||
| 2019-06-19 | 2019-04-30 | 4 | Kennedy Timothy | BIOC | Employee Stock Option (right to buy) | D | 0,91 | 400 000 | 400 000 | |||||
| 2018-10-02 | 2018-09-28 | 4 | Hendrick Edwin | BIOC | Employee Stock Option (right to buy) | D | 2,75 | 45 000 | 45 000 | |||||
| 2018-07-02 | 2018-06-29 | 4 | Gerhardt Bruce | BIOC | Employee Stock Option (right to buy) | D | 0,20 | 15 000 | 15 000 | |||||
| 2018-07-02 | 2018-06-29 | 4 | HUEBNER BRUCE A | BIOC | Employee Stock Option (right to buy) | D | 0,20 | 15 000 | 15 000 | |||||
| 2018-07-02 | 2018-06-29 | 4 | ROYSTON IVOR | BIOC | Employee Stock Option (right to buy) | D | 0,20 | 15 000 | 15 000 | |||||
| 2018-07-02 | 2018-06-29 | 4 | Wilson Margaret Faye | BIOC | Employee Stock Option (right to buy) | D | 0,20 | 15 000 | 15 000 | |||||
| 2018-07-02 | 2018-06-29 | 4 | HALE DAVID F | BIOC | Employee Stock Option (right to buy) | D | 0,20 | 15 000 | 15 000 | |||||
| 2018-07-02 | 2018-06-29 | 4 | Chandler Marsha Alpert | BIOC | Employee Stock Option (right to buy) | D | 0,20 | 15 000 | 15 000 | |||||
| 2018-06-06 | 2018-01-30 | 4 | Gerhardt Bruce | BIOC | Warrant to Purchase Common Stock | D | 0,50 | 25 000 | 25 000 | |||||
| 2018-06-06 | 2018-01-30 | 4 | Gerhardt Bruce | BIOC | Common Stock | D | 25 000 | 98 303 | ||||||
| 2017-08-17 | 3 | Ally Bridge LB Healthcare Master Fund Ltd | BIOC | Common Stock | D | 6 295 334 | ||||||||
| 2017-08-17 | 3 | Ally Bridge LB Healthcare Master Fund Ltd | BIOC | Common Stock | D | 6 295 334 | ||||||||
| 2017-08-17 | 3 | Ally Bridge LB Healthcare Master Fund Ltd | BIOC | Common Stock | D | 6 295 334 | ||||||||
| 2017-08-17 | 3 | Ally Bridge LB Healthcare Master Fund Ltd | BIOC | Common Stock | D | 6 295 334 | ||||||||
| 2017-08-17 | 3 | Ally Bridge LB Healthcare Master Fund Ltd | BIOC | Common Stock | D | 6 295 334 | ||||||||
| 2017-06-02 | 2017-05-31 | 4 | HALE DAVID F | BIOC | Employee Stock Option (right to buy) | D | 1,50 | 15 000 | 15 000 | |||||
| 2017-06-02 | 2017-05-31 | 4 | HUEBNER BRUCE A | BIOC | Employee Stock Option (right to buy) | D | 1,50 | 15 000 | 15 000 | |||||
| 2017-06-02 | 2017-05-31 | 4 | Neff Edward A. | BIOC | Employee Stock Option (right to buy) | D | 1,50 | 15 000 | 15 000 | |||||
| 2017-06-02 | 2017-05-31 | 4 | ROYSTON IVOR | BIOC | Employee Stock Option (right to buy) | D | 1,50 | 15 000 | 15 000 | |||||
| 2017-06-02 | 2017-05-31 | 4 | Wilson Margaret Faye | BIOC | Employee Stock Option (right to buy) | D | 1,50 | 15 000 | 15 000 | |||||
| 2017-06-02 | 2017-05-31 | 4 | Nall Michael W. | BIOC | Employee Stock Option (right to buy) | D | 1,50 | 300 000 | 300 000 | |||||
| 2017-06-02 | 2017-05-31 | 4 | Nall Michael W. | BIOC | Common Stock | D | 50 000 | 75 000 | ||||||
| 2017-06-02 | 2017-05-31 | 4 | Kennedy Timothy | BIOC | Employee Stock Option (right to buy) | D | 1,50 | 50 000 | 50 000 | |||||
| 2017-06-02 | 2017-05-31 | 4 | Kennedy Timothy | BIOC | Common Stock | D | 25 000 | 86 363 | ||||||
| 2017-06-02 | 2017-05-31 | 4 | ARNOLD LYLE J | BIOC | Employee Stock Option (right to buy) | D | 1,50 | 75 000 | 75 000 | |||||
| 2017-06-02 | 2017-05-31 | 4 | ARNOLD LYLE J | BIOC | Common Stock | D | 25 000 | 90 238 | ||||||
| 2017-06-02 | 2017-05-31 | 4 | Singh Veena | BIOC | Employee Stock Option (right to buy) | D | 1,50 | 50 000 | 50 000 | |||||
| 2017-06-02 | 2017-05-31 | 4 | Singh Veena | BIOC | Common Stock | D | 25 000 | 51 666 | ||||||
| 2017-06-02 | 2017-05-31 | 4 | Chandler Marsha Alpert | BIOC | Employee Stock Option (right to buy) | D | 1,50 | 15 000 | 15 000 | |||||
| 2017-06-02 | 2017-05-31 | 4 | Gerhardt Bruce | BIOC | Employee Stock Option (right to buy) | D | 1,50 | 15 000 | 15 000 | |||||
| 2017-04-03 | 2017-03-31 | 4 | Neff Edward A. | BIOC | Employee Stock Option (right to buy) | D | 2,13 | 4 166 | 4 166 | |||||
| 2017-04-03 | 2017-03-31 | 4 | Wilson Margaret Faye | BIOC | Employee Stock Option (right to buy) | D | 2,13 | 4 166 | 4 166 | |||||
| 2017-04-03 | 2017-03-31 | 4 | Chandler Marsha Alpert | BIOC | Employee Stock Option (right to buy) | D | 2,13 | 4 166 | 4 166 | |||||
| 2017-04-03 | 2017-03-31 | 4 | HALE DAVID F | BIOC | Employee Stock Option (right to buy) | D | 2,13 | 4 166 | 4 166 | |||||
| 2017-04-03 | 2017-03-31 | 4 | ROYSTON IVOR | BIOC | Employee Stock Option (right to buy) | D | 2,13 | 4 166 | 4 166 | |||||
| 2017-04-03 | 2017-03-31 | 4 | Gerhardt Bruce | BIOC | Employee Stock Option (right to buy) | D | 2,13 | 4 166 | 4 166 | |||||
| 2017-04-03 | 2017-03-31 | 4 | HUEBNER BRUCE A | BIOC | Employee Stock Option (right to buy) | D | 2,13 | 4 166 | 4 166 | |||||
| 2017-03-29 | 2015-03-16 | 4 | ROYSTON IVOR | BIOC | Common Stock | D | 8,7600 | 5 667 | 50 | 17 294 | ||||
| 2017-03-22 | 2017-03-21 | 4 | Kennedy Timothy | BIOC | Employee stock option (right to buy) | D | 1,95 | 16 383 | 16 383 | |||||
| 2017-03-22 | 2017-03-21 | 4 | Nall Michael W. | BIOC | Employee stock option (right to buy) | D | 4,02 | 10 000 | 10 000 | |||||
| 2017-03-22 | 2017-03-21 | 4 | Nall Michael W. | BIOC | Employee stock option (right to buy) | D | 6,03 | 6 333 | 6 333 | |||||
| 2017-02-28 | 2017-02-28 | 4 | TERRY MICHAEL J | BIOC | Employee Stock Option (right to buy) | D | 2,05 | 50 000 | 50 000 | |||||
| 2017-02-16 | 3 | TERRY MICHAEL J | BIOC | Common Stock | D | 5 800 | ||||||||
| 2017-02-16 | 3 | TERRY MICHAEL J | BIOC | Common Stock | D | 5 800 | ||||||||
| 2017-01-26 | 2017-01-19 | 4 | Ally Bridge LB Healthcare Master Fund Ltd | BIOC | Common Stock | D | 1,1000 | -254 893 | -280 | 0 | ||||
| 2017-01-26 | 2017-01-18 | 4 | Ally Bridge LB Healthcare Master Fund Ltd | BIOC | Common Stock | D | 1,1000 | -549 708 | -605 | 254 893 | ||||
| 2017-01-26 | 2017-01-17 | 4 | Ally Bridge LB Healthcare Master Fund Ltd | BIOC | Common Stock | D | 1,1000 | -876 399 | -964 | 804 601 | ||||
| 2016-10-24 | 3 | Li Bin | BIOC | Common Stock | D | 3 362 000 | ||||||||
| 2016-10-24 | 3 | Li Bin | BIOC | Common Stock | D | 3 362 000 | ||||||||
| 2016-10-24 | 3 | Li Bin | BIOC | Common Stock | D | 3 362 000 | ||||||||
| 2016-10-24 | 3 | Li Bin | BIOC | Common Stock | D | 3 362 000 | ||||||||
| 2016-10-24 | 3 | Li Bin | BIOC | Common Stock | D | 3 362 000 | ||||||||
| 2016-10-21 | 3/A | HALE DAVID F By Trust | BIOC | Common Stock | I | 10 204 | ||||||||
| 2016-10-21 | 2016-10-19 | 4 | HALE DAVID F By LLC | BIOC | Warrant to Purchase Common Stock | I | 1,10 | 90 909 | 90 909 | |||||
| 2016-10-21 | 2016-10-19 | 4 | HALE DAVID F By LLC | BIOC | Common Stock | I | 1,1000 | 90 909 | 100 | 109 099 | ||||
| 2016-10-21 | 2016-06-16 | 4 | HALE DAVID F By trust | BIOC | Common Stock | I | 13 334 | 16 736 | ||||||
| 2016-10-21 | 2016-06-16 | 4 | HALE DAVID F By LLC | BIOC | Common Stock | I | -13 334 | 18 190 | ||||||
| 2016-10-21 | 2016-10-19 | 4 | HUEBNER BRUCE A | BIOC | Warrant to Purchase Common Stock | D | 1,10 | 20 000 | 20 000 | |||||
| 2016-10-21 | 2016-10-19 | 4 | HUEBNER BRUCE A | BIOC | Common Stock | D | 1,1000 | 20 000 | 22 | 24 000 | ||||
| 2016-10-21 | 2016-10-19 | 4 | ARNOLD LYLE J | BIOC | Warrant to Purchase Common Stock | D | 1,10 | 45 000 | 45 000 | |||||
| 2016-10-21 | 2016-10-19 | 4 | ARNOLD LYLE J | BIOC | Common Stock | D | 1,1000 | 45 000 | 50 | 65 238 | ||||
| 2016-10-21 | 2016-10-19 | 4 | Wilson Margaret Faye | BIOC | Warrant to Purchase Common Stock | D | 1,10 | 13 636 | 13 636 | |||||
| 2016-10-21 | 2016-10-19 | 4 | Wilson Margaret Faye | BIOC | Common Stock | D | 1,1000 | 13 636 | 15 | 25 067 | ||||
| 2016-10-21 | 2016-10-19 | 4 | Gerhardt Bruce | BIOC | Warrant to Purchase Common Stock | D | 1,10 | 50 000 | 50 000 | |||||
| 2016-10-21 | 2016-10-19 | 4 | Gerhardt Bruce | BIOC | Common Stock | D | 1,1000 | 50 000 | 55 | 73 304 | ||||
| 2016-10-21 | 2016-10-19 | 4 | Chandler Marsha Alpert | BIOC | Warrant to Purchase Common Stock | D | 1,10 | 4 545 | 4 545 | |||||
| 2016-10-21 | 2016-10-19 | 4 | Chandler Marsha Alpert | BIOC | Common Stock | D | 1,1000 | 4 545 | 5 | 5 212 | ||||
| 2016-10-21 | 2014-03-04 | 4 | Chandler Marsha Alpert By trust | BIOC | Common Stock | I | 1 693 | 1 693 | ||||||
| 2016-10-21 | 2014-03-04 | 4 | Chandler Marsha Alpert | BIOC | Common Stock | D | -1 693 | 667 | ||||||
| 2016-10-21 | 2016-10-19 | 4 | Nall Michael W. | BIOC | Warrant to Purchase Common Stock | D | 1,10 | 36 363 | 36 363 | |||||
| 2016-10-21 | 2016-10-19 | 4 | Nall Michael W. By trust | BIOC | Common Stock | I | 1,1000 | 36 363 | 40 | 49 575 | ||||
| 2016-10-21 | 2016-03-09 | 4 | Nall Michael W. By trust | BIOC | Common Stock | I | 4 450 | 13 212 | ||||||
| 2016-10-21 | 2016-03-09 | 4 | Nall Michael W. | BIOC | Common Stock | D | -4 450 | 25 000 | ||||||
| 2016-10-21 | 2015-09-01 | 4 | Nall Michael W. By trust | BIOC | Common Stock | I | 4 762 | 8 762 | ||||||
| 2016-10-21 | 2015-09-01 | 4 | Nall Michael W. | BIOC | Common Stock | D | -4 762 | 29 450 | ||||||
| 2016-10-21 | 2015-04-30 | 4 | Nall Michael W. By trust | BIOC | Common Stock | I | 4 000 | 4 000 | ||||||
| 2016-10-21 | 2015-04-30 | 4 | Nall Michael W. | BIOC | Common Stock | D | -4 000 | 34 212 | ||||||
| 2016-10-21 | 2016-10-19 | 4 | Neff Edward A. | BIOC | Warrant to Purchase Common Stock | D | 1,10 | 227 272 | 227 272 | |||||
| 2016-10-21 | 2016-10-19 | 4 | Neff Edward A. By corporation | BIOC | Common Stock | I | 1,1000 | 227 272 | 250 | 289 735 | ||||
| 2016-10-21 | 2016-10-19 | 4 | Reiss Claire By trusts | BIOC | Warrant to Purchase Common Stock | I | 1,10 | 227 272 | 227 272 | |||||
| 2016-10-21 | 2016-10-19 | 4 | Reiss Claire By trusts | BIOC | Common Stock | I | 1,1000 | 227 272 | 250 | 1 046 613 | ||||
| 2016-10-21 | 2016-10-19 | 4 | Singh Veena | BIOC | Warrant to Purchase Common Stock | D | 1,10 | 10 000 | 10 000 | |||||
| 2016-10-21 | 2016-10-19 | 4 | Singh Veena | BIOC | Common Stock | D | 1,1000 | 10 000 | 11 | 26 666 | ||||
| 2016-10-21 | 2016-10-19 | 4 | Kennedy Timothy | BIOC | Warrant to Purchase Common Stock | D | 1,10 | 36 363 | 36 363 | |||||
| 2016-10-21 | 2016-10-19 | 4 | Kennedy Timothy | BIOC | Common Stock | D | 1,1000 | 36 363 | 40 | 61 363 | ||||
| 2016-08-01 | 2016-07-29 | 4 | Kennedy Timothy | BIOC | Employee Stock Option (right to buy) | D | 0,65 | 200 000 | 200 000 | |||||
| 2016-08-01 | 2016-07-29 | 4 | Kennedy Timothy | BIOC | Common Stock | D | 75 000 | 75 000 | ||||||
| 2016-07-07 | 2016-07-06 | 4 | ARNOLD LYLE J | BIOC | Common Stock | D | 50 000 | 60 714 | ||||||
| 2016-07-07 | 2016-07-06 | 4 | Nall Michael W. | BIOC | Common Stock | D | 75 000 | 114 634 | ||||||
| 2016-07-07 | 2016-07-06 | 4 | Singh Veena | BIOC | Common Stock | D | 50 000 | 50 000 | ||||||
| 2016-05-05 | 3/A | Reiss Claire By corporation | BIOC | Common Stock | I | 14 012 | ||||||||
| 2016-05-05 | 2016-05-04 | 4 | HALE DAVID F | BIOC | Warrant to Purchase Common Stock | D | 1,30 | 35 000 | 35 000 | |||||
| 2016-05-05 | 2016-05-04 | 4 | HALE DAVID F | BIOC | Common Stock | D | 1,0000 | 50 000 | 50 | 138 356 | ||||
| 2016-05-05 | 2016-05-04 | 4 | Gerhardt Bruce | BIOC | Warrant to Purchase Common Stock | D | 1,30 | 17 500 | 17 500 | |||||
| 2016-05-05 | 2016-05-04 | 4 | Gerhardt Bruce | BIOC | Common Stock | D | 1,0000 | 25 000 | 25 | 58 985 | ||||
| 2016-05-05 | 2016-05-04 | 4 | Neff Edward A. | BIOC | Warrant to Purchase Common Stock | D | 1,30 | 70 000 | 70 000 | |||||
| 2016-05-05 | 2016-05-04 | 4 | Neff Edward A. | BIOC | Common Stock | D | 1,0000 | 100 000 | 100 | 112 913 | ||||
| 2016-05-05 | 2016-05-04 | 4 | Reiss Claire By trusts | BIOC | Warrant to Purchase Common Stock | I | 1,30 | 429 991 | 429 991 | |||||
| 2016-05-05 | 2016-05-04 | 4 | Reiss Claire By trusts | BIOC | Common Stock | I | 1,0000 | 614 273 | 614 | 2 458 016 | ||||
| 2016-03-01 | 2016-02-29 | 4 | ARNOLD LYLE J | BIOC | Employee Stock Option (right to buy) | D | 1,34 | 25 000 | 25 000 | |||||
| 2016-03-01 | 2016-02-29 | 4 | Nall Michael W. | BIOC | Employee stock option (right to buy) | D | 1,34 | 50 000 | 50 000 | |||||
| 2016-03-01 | 2016-02-29 | 4 | Nall Michael W. | BIOC | Common Stock | D | 13 348 | 39 634 | ||||||
| 2016-03-01 | 2016-02-29 | 4 | Trivedi Raaj | BIOC | Employee Stock Option (right to buy) | D | 1,34 | 17 500 | 17 500 | |||||
| 2016-03-01 | 2016-02-29 | 4 | Singh Veena | BIOC | Employee Stock Option (right to buy) | D | 1,34 | 50 000 | 50 000 | |||||
| 2016-01-04 | 2015-12-31 | 4 | Wilson Margaret Faye | BIOC | Stock Option (right to buy) | D | 1,38 | 12 500 | 12 500 | |||||
| 2016-01-04 | 2015-12-31 | 4 | Neff Edward A. | BIOC | Stock Option (right to buy) | D | 1,38 | 12 500 | 12 500 | |||||
| 2016-01-04 | 2015-12-31 | 4 | Gerhardt Bruce | BIOC | Stock Option (right to buy) | D | 1,38 | 12 500 | 12 500 | |||||
| 2016-01-04 | 2015-12-31 | 4 | Chandler Marsha Alpert | BIOC | Stock Option (right to buy) | D | 1,38 | 12 500 | 12 500 | |||||
| 2016-01-04 | 2015-12-31 | 4 | ROYSTON IVOR | BIOC | Stock Option (right to buy) | D | 1,38 | 12 500 | 12 500 | |||||
| 2016-01-04 | 2015-12-31 | 4 | HALE DAVID F | BIOC | Stock Option (right to buy) | D | 1,38 | 12 500 | 12 500 | |||||
| 2016-01-04 | 2015-12-31 | 4 | HUEBNER BRUCE A | BIOC | Stock Option (right to buy) | D | 1,38 | 12 500 | 12 500 | |||||
| 2015-11-10 | 2015-11-09 | 4 | ROYSTON IVOR | BIOC | Restricted Stock Units | D | -9 285 | 0 | ||||||
| 2015-11-10 | 2015-11-09 | 4 | ROYSTON IVOR | BIOC | Common Stock | D | 9 285 | 34 878 | ||||||
| 2015-11-10 | 2015-11-09 | 4 | HALE DAVID F | BIOC | Restricted Stock Units | D | -53 662 | 0 | ||||||
| 2015-11-10 | 2015-11-09 | 4 | HALE DAVID F | BIOC | Restricted Stock Units | D | -10 204 | 0 | ||||||
| 2015-11-10 | 2015-11-09 | 4 | HALE DAVID F | BIOC | Common Stock | D | 53 662 | 88 356 | ||||||
| 2015-11-10 | 2015-11-09 | 4 | HALE DAVID F | BIOC | Common Stock | D | 10 204 | 34 694 | ||||||
| 2015-09-02 | 2015-08-31 | 4 | Singh Veena | BIOC | Employee Stock Option (right to buy) | D | 2,01 | 175 000 | 175 000 | |||||
| 2015-09-02 | 2015-08-31 | 4 | Trivedi Raaj | BIOC | Employee Stock Option (right to buy) | D | 2,01 | 47 000 | 47 000 | |||||
| 2015-09-02 | 2015-08-31 | 4 | Nall Michael W. | BIOC | Employee Stock Option (right to buy) | D | 2,01 | 150 000 | 150 000 | |||||
| 2015-09-02 | 2015-08-31 | 4 | FOLETTA MARK G | BIOC | Employee Stock Option (right to buy) | D | 2,01 | 50 000 | 50 000 | |||||
| 2015-09-02 | 2015-08-31 | 4 | ARNOLD LYLE J | BIOC | Employee Stock Option (right to buy) | D | 2,01 | 175 000 | 175 000 | |||||
| 2015-08-25 | 2015-08-24 | 4 | Nall Michael W. | BIOC | Restricted Stock Units | D | -14 286 | 0 | ||||||
| 2015-08-25 | 2015-08-24 | 4 | Nall Michael W. | BIOC | Common Stock | D | 14 286 | 26 286 | ||||||
| 2015-08-25 | 2015-08-24 | 4 | ARNOLD LYLE J | BIOC | Restricted Stock Units | D | -10 714 | 0 | ||||||
| 2015-08-25 | 2015-08-24 | 4 | ARNOLD LYLE J | BIOC | Common Stock | D | 10 714 | 10 714 | ||||||
| 2015-08-25 | 2015-08-24 | 4 | HALE DAVID F | BIOC | Restricted Stock Units | D | -14 286 | 0 | ||||||
| 2015-08-25 | 2015-08-24 | 4 | HALE DAVID F | BIOC | Common Stock | D | 14 286 | 24 490 | ||||||
| 2015-08-20 | 3 | FOLETTA MARK G | BIOC | No securities are beneficially owned | D | 0 | ||||||||
| 2015-07-08 | 2015-05-24 | 4 | Gerhardt Bruce | BIOC | Restricted Stock Units | D | -8 735 | 0 | ||||||
| 2015-07-08 | 2015-05-24 | 4 | Gerhardt Bruce | BIOC | Common Stock | D | 8 735 | 33 985 | ||||||
| 2015-07-08 | 2015-05-24 | 4 | Neff Edward A. | BIOC | Restricted Stock Units | D | -8 735 | 0 | ||||||
| 2015-07-08 | 2015-05-24 | 4 | Neff Edward A. | BIOC | Common Stock | D | 8 735 | 12 913 | ||||||
| 2015-07-08 | 2015-05-24 | 4 | ROYSTON IVOR | BIOC | Restricted Stock Units | D | -8 735 | 0 | ||||||
| 2015-07-08 | 2015-05-24 | 4 | ROYSTON IVOR | BIOC | Common Stock | D | 8 735 | 25 593 | ||||||
| 2015-07-08 | 2015-05-24 | 4 | Wilson Margaret Faye | BIOC | Restricted Stock Units | D | -14 285 | 0 | ||||||
| 2015-07-08 | 2015-05-24 | 4 | Wilson Margaret Faye | BIOC | Common Stock | D | 14 285 | 23 359 | ||||||
| 2015-06-02 | 2015-06-01 | 4 | Singh Veena By spouse | BIOC | Common Stock | I | 3,1000 | 3 200 | 10 | 5 000 | ||||
| 2015-06-02 | 2015-05-29 | 4 | Singh Veena By spouse | BIOC | Common Stock | I | 3,0500 | 1 800 | 5 | 1 800 | ||||
| 2015-02-18 | 2015-02-13 | 4 | ROYSTON IVOR By Reporting Person's retirement account | BIOC | Warrant to Purchase Common Stock | I | 1,56 | 12 000 | 12 000 | |||||
| 2015-02-18 | 2015-02-13 | 4 | ROYSTON IVOR By Reporting Person's retirement account | BIOC | Common Stock | I | 1,2500 | 12 000 | 15 | 16 858 | ||||
| 2015-02-18 | 2015-02-13 | 4 | HALE DAVID F By LLC | BIOC | Warrant to Purchase Common Stock | I | 1,56 | 40 000 | 40 000 | |||||
| 2015-02-18 | 2015-02-13 | 4 | HALE DAVID F By LLC | BIOC | Common Stock | I | 1,2500 | 40 000 | 50 | 94 570 | ||||
| 2015-02-18 | 2015-02-13 | 4 | Neff Edward A. By corporation | BIOC | Warrant to Purchase Common Stock | I | 1,56 | 40 000 | 40 000 | |||||
| 2015-02-18 | 2015-02-13 | 4 | Neff Edward A. By corporation | BIOC | Common Stock | I | 1,2500 | 40 000 | 50 | 187 386 | ||||
| 2015-02-18 | 2015-02-13 | 4 | Nall Michael W. | BIOC | Warrant to Purchase Common Stock | D | 1,56 | 12 000 | 12 000 | |||||
| 2015-02-18 | 2015-02-13 | 4 | Nall Michael W. | BIOC | Common Stock | D | 1,2500 | 12 000 | 15 | 12 000 | ||||
| 2015-02-18 | 2015-02-13 | 4 | Chandler Marsha Alpert | BIOC | Warrant to Purchase Common Stock | D | 1,56 | 2 000 | 2 000 | |||||
| 2015-02-18 | 2015-02-13 | 4 | Chandler Marsha Alpert | BIOC | Common Stock | D | 1,2500 | 2 000 | 2 | 7 078 | ||||
| 2015-02-18 | 2015-02-13 | 4 | Gerhardt Bruce | BIOC | Warrant to Purchase Common Stock | D | 1,56 | 20 000 | 20 000 | |||||
| 2015-02-18 | 2015-02-13 | 4 | Gerhardt Bruce | BIOC | Common Stock | D | 1,2500 | 20 000 | 25 | 25 250 | ||||
| 2015-02-18 | 2015-02-13 | 4 | HUEBNER BRUCE A | BIOC | Warrant to Purchase Common Stock | D | 1,56 | 12 000 | 12 000 | |||||
| 2015-02-18 | 2015-02-13 | 4 | HUEBNER BRUCE A | BIOC | Common Stock | D | 1,2500 | 12 000 | 15 | 12 000 | ||||
| 2015-02-18 | 2015-02-13 | 4 | Wilson Margaret Faye | BIOC | Warrant to Purchase Common Stock | D | 1,56 | 4 000 | 4 000 | |||||
| 2015-02-18 | 2015-02-13 | 4 | Wilson Margaret Faye | BIOC | Common Stock | D | 1,2500 | 4 000 | 5 | 9 074 | ||||
| 2014-12-22 | 2014-12-18 | 4 | Singh Veena | BIOC | Stock option (right to buy) | D | 2,79 | 40 000 | 40 000 | |||||
| 2014-06-16 | 2014-06-12 | 4 | Nall Michael W. | BIOC | Stock Options (right to buy) | D | 5,35 | 75 000 | 75 000 | |||||
| 2014-06-06 | 3 | Trivedi Raaj | BIOC | No securities are beneficially owned | D | 0 | ||||||||
| 2014-06-06 | 2014-03-24 | 4 | Trivedi Raaj | BIOC | Stock Options (right to buy) | D | 7,50 | 43 000 | 43 000 | |||||
| 2014-05-20 | 2014-05-16 | 4 | Kachioff William G | BIOC | Stock Options (right to buy) | D | 4,38 | 50 000 | 50 000 | |||||
| 2014-05-20 | 2014-05-16 | 4 | ARNOLD LYLE J | BIOC | Stock Options (right to buy) | D | 4,38 | 35 000 | 35 000 | |||||
| 2014-05-20 | 2014-05-16 | 4 | Bischoff Farideh Z. | BIOC | Stock Options (right to buy) | D | 4,38 | 35 000 | 35 000 | |||||
| 2014-03-05 | 2014-02-10 | 4/A | Reiss Claire By trust | BIOC | Convertible Note (right to buy) | I | 10,00 | -163 399 | 0 | |||||
| 2014-03-05 | 2014-02-10 | 4/A | Reiss Claire By trusts | BIOC | Common Stock | I | 10,0000 | 420 430 | 4 204 | 1 843 743 | ||||
| 2014-02-24 | 2014-02-21 | 4 | HALE DAVID F | BIOC | Stock Options (right to buy) | D | 9,11 | 53 108 | 53 108 | |||||
| 2014-02-24 | 2014-02-21 | 4 | Kachioff William G | BIOC | Stock Options (right to buy) | D | 9,11 | 1 190 | 1 190 | |||||
| 2014-02-18 | 2014-02-13 | 4 | HALE DAVID F | BIOC | Stock Options (right to buy) | D | 8,88 | 70 000 | 70 000 | |||||
| 2014-02-18 | 2014-02-13 | 4 | ROYSTON IVOR | BIOC | Stock Options (right to buy) | D | 8,88 | 26 500 | 26 500 | |||||
| 2014-02-18 | 2014-02-13 | 4 | HUEBNER BRUCE A | BIOC | Stock Options (right to buy) | D | 8,88 | 22 000 | 22 000 | |||||
| 2014-02-18 | 2014-02-13 | 4 | Wilson Margaret Faye | BIOC | Stock Options (right to buy) | D | 8,88 | 51 000 | 51 000 | |||||
| 2014-02-18 | 2014-02-13 | 4 | Gerhardt Bruce | BIOC | Stock Options (right to buy) | D | 8,88 | 23 000 | 23 000 | |||||
| 2014-02-18 | 2014-02-13 | 4 | Chandler Marsha Alpert | BIOC | Stock Options (right to buy) | D | 8,88 | 23 000 | 23 000 | |||||
| 2014-02-18 | 2014-02-13 | 4 | Neff Edward A. | BIOC | Stock Options (right to buy) | D | 8,88 | 23 000 | 23 000 | |||||
| 2014-02-12 | 2014-02-10 | 4 | ROYSTON IVOR | BIOC | Warrants (right to buy) | D | 10,00 | 2 500 | 2 500 | |||||
| 2014-02-12 | 2014-02-10 | 4 | ROYSTON IVOR | BIOC | Restricted Stock Units (right to buy) | D | 9 285 | 9 285 | ||||||
| 2014-02-12 | 2014-02-10 | 4 | HALE DAVID F By LLC | BIOC | Warrants (right to buy) | I | 10,00 | 36 302 | 36 302 | |||||
| 2014-02-12 | 2014-02-10 | 4 | HALE DAVID F By LLC | BIOC | Warrants (right to buy) | I | 10,00 | 22 175 | 22 175 | |||||
| 2014-02-12 | 2014-02-10 | 4 | HALE DAVID F | BIOC | Issuer?s repurchase right (obligation to sell) | D | 4,6200 | -10 204 | -47 | 0 | ||||
| 2014-02-12 | 2014-02-10 | 4 | HALE DAVID F | BIOC | Restricted Stock Units (right to buy) | D | 53 662 | 53 662 | ||||||
| 2014-02-12 | 2014-02-10 | 4 | HALE DAVID F | BIOC | Restricted Stock Units (right to buy) | D | 10 204 | 10 204 | ||||||
| 2014-02-12 | 2014-02-10 | 4 | HALE DAVID F By LLC | BIOC | Convertible Notes (right to buy) | I | 10,00 | -47 181 | 0 | |||||
| 2014-02-12 | 2014-02-10 | 4 | HALE DAVID F By LLC | BIOC | Common Stock | I | 10,0000 | 47 181 | 472 | 54 570 | ||||
| 2014-02-12 | 2014-02-10 | 4 | Wilson Margaret Faye | BIOC | Warrants (right to buy) | D | 10,00 | 1 250 | 1 250 | |||||
| 2014-02-12 | 2014-02-10 | 4 | Wilson Margaret Faye | BIOC | Convertible Note (right to buy) | D | 10,00 | -2 650 | 0 | |||||
| 2014-02-12 | 2014-02-10 | 4 | Wilson Margaret Faye | BIOC | Common Stock | D | 10,0000 | 2 650 | 26 | 5 074 | ||||
| 2014-02-12 | 2014-02-10 | 4 | Gerhardt Bruce | BIOC | Warrants (right to buy) | D | 10,00 | 2 500 | 2 500 | |||||
| 2014-02-12 | 2014-02-10 | 4 | Gerhardt Bruce | BIOC | Warrants (right to buy) | D | 10,00 | 500 | 500 | |||||
| 2014-02-12 | 2014-02-10 | 4 | Gerhardt Bruce | BIOC | Convertible Note (right to buy) | D | 10,00 | -1 055 | 0 | |||||
| 2014-02-12 | 2014-02-10 | 4 | Gerhardt Bruce | BIOC | Common Stock | D | 10,0000 | 1 055 | 11 | 5 250 | ||||
| 2014-02-12 | 2014-02-10 | 4 | Chandler Marsha Alpert | BIOC | Warrants (right to buy) | D | 10,00 | 2 500 | 2 500 | |||||
| 2014-02-12 | 2014-02-10 | 4 | Chandler Marsha Alpert | BIOC | Convertible Note (right to buy) | D | 10,00 | -5 078 | 0 | |||||
| 2014-02-12 | 2014-02-10 | 4 | Chandler Marsha Alpert | BIOC | Common Stock | D | 10,0000 | 5 078 | 51 | 5 078 | ||||
| 2014-02-12 | 2014-02-10 | 4 | Neff Edward A. | BIOC | Warrants (right to buy) | D | 10,00 | 28 801 | 28 801 | |||||
| 2014-02-12 | 2014-02-10 | 4 | Neff Edward A. By corporation | BIOC | Warrants (right to buy) | I | 10,00 | 51 250 | 51 250 | |||||
| 2014-02-12 | 2014-02-10 | 4 | Neff Edward A. By corporation | BIOC | Convertible Notes (right to buy) | I | 10,00 | -108 140 | 0 | |||||
| 2014-02-12 | 2014-02-10 | 4 | Neff Edward A. By corporation | BIOC | Common Stock | I | 10,0000 | 108 140 | 1 081 | 147 386 | ||||
| 2014-02-12 | 2014-02-10 | 4 | Reiss Claire By trust | BIOC | Warrants (right to buy) | I | 10,00 | 58 802 | 58 802 | |||||
| 2014-02-12 | 2014-02-10 | 4 | Reiss Claire By corporation | BIOC | Warrants (right to buy) | I | 10,00 | 6 250 | 6 250 | |||||
| 2014-02-12 | 2014-02-10 | 4 | Reiss Claire By trusts | BIOC | Warrants (right to buy) | I | 10,00 | 119 000 | 119 000 | |||||
| 2014-02-12 | 2014-02-10 | 4 | Reiss Claire By corporation | BIOC | Convertible Notes (right to buy) | I | 10,00 | -13 453 | 0 | |||||
| 2014-02-12 | 2014-02-10 | 4 | Reiss Claire By trust | BIOC | Convertible Notes (right to buy) | I | 10,00 | -257 031 | 0 | |||||
| 2014-02-12 | 2014-02-10 | 4 | Reiss Claire By corporation | BIOC | Common Stock | I | 10,0000 | 13 453 | 135 | 14 012 | ||||
| 2014-02-12 | 2014-02-10 | 4 | Reiss Claire By trusts | BIOC | Common Stock | I | 10,0000 | 257 031 | 2 570 | 1 680 344 | ||||
| 2014-02-04 | 3 | HALE DAVID F | BIOC | Common Stock | D | 10 204 | ||||||||
| 2014-02-04 | 3 | HALE DAVID F By LLC | BIOC | Common Stock | I | 7 389 | ||||||||
| 2014-02-04 | 3 | ROYSTON IVOR By Reporting Person?s retirement account | BIOC | Common Stock | I | 4 858 | ||||||||
| 2014-02-04 | 3 | Wilson Margaret Faye By Reporting Person?s retirement account | BIOC | Common Stock | I | 2 374 | ||||||||
| 2014-02-04 | 3 | Wilson Margaret Faye | BIOC | Common Stock | D | 2 424 | ||||||||
| 2014-02-04 | 3 | Wilson Margaret Faye By LLC | BIOC | Common Stock | I | 1 417 | ||||||||
| 2014-02-04 | 3 | Gerhardt Bruce | BIOC | Common Stock | D | 4 195 | ||||||||
| 2014-02-04 | 3 | Neff Edward A. By corporation | BIOC | Common Stock | I | 39 246 | ||||||||
| 2014-02-04 | 3 | Neff Edward A. | BIOC | Common Stock | D | 4 178 | ||||||||
| 2014-02-04 | 3 | Reiss Claire By corporation | BIOC | Common Stock | I | 559 | ||||||||
| 2014-02-04 | 3 | Reiss Claire By trusts | BIOC | Common Stock | I | 1 423 313 |
P
Otwarty rynek lub prywatny zakup niepochodnych lub pochodnych papierów wartościowych
S
Otwarty rynek lub prywatna sprzedaż niepochodnych lub pochodnych papierów wartościowych
A
Grant, nagroda lub inne nabycie papierów wartościowych od spółki (np. opcja)
C
Konwersja instrumentu pochodnego
D
Sprzedaż lub przeniesienie papierów wartościowych z powrotem do spółki
F
Zapłata ceny wykonania lub zobowiązania podatkowego z wykorzystaniem części papierów wartościowych otrzymanych od spółki
G
Darowizna papierów wartościowych przez lub na rzecz insidera
K
Swapy kapitałowe i podobne transakcje zabezpieczające
M
Wykonanie lub konwersja pochodnego papieru wartościowego otrzymanego od spółki (takiego jak opcja)
V
Transakcja dobrowolnie zgłoszona na Formularzu 4
J
Inne (wraz z przypisem opisującym transakcję)
